Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
AEON Biopharma ( (AEON) ) just unveiled an update.
At a recent Special Meeting, AEON Biopharma’s stockholders approved several key proposals. These included an amendment to increase the number of authorized shares of Common Stock, granting the board discretionary authority for a reverse stock split, authorizing the issuance of warrants and shares in compliance with NYSE American listing rules, and approving potential adjournments to solicit additional proxies if needed. These decisions are poised to impact the company’s capital structure and market operations significantly.
More about AEON Biopharma
YTD Price Performance: -78.14%
Average Trading Volume: 18,494,218
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $9.62M
Find detailed analytics on AEON stock on TipRanks’ Stock Analysis page.